133 related articles for article (PubMed ID: 31060800)
1. Use of inhaled imipenem/cilastatin in pediatric patients with cystic fibrosis: A case series.
Jones LA; Doucette L; Dellon EP; Esther CR; McKinzie CJ
J Cyst Fibros; 2019 Jul; 18(4):e42-e44. PubMed ID: 31060800
[TBL] [Abstract][Full Text] [Related]
2. Imipenem/cilastatin, an alternative treatment of pseudomonas infection in cystic fibrosis.
Strandvik B; Malmborg AS; Bergan T; Michalsen H; Storrøsten OT; Wretlind B
J Antimicrob Chemother; 1988 Apr; 21(4):471-80. PubMed ID: 3132441
[TBL] [Abstract][Full Text] [Related]
3. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS; Pressler T; Jensen T; Rosdahl VT; Bentzon MW; Høiby N; Koch C
J Antimicrob Chemother; 1987 Jan; 19(1):101-7. PubMed ID: 3104273
[TBL] [Abstract][Full Text] [Related]
4. Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial.
Portsmouth S; van Veenhuyzen D; Echols R; Machida M; Ferreira JCA; Ariyasu M; Tenke P; Nagata TD
Lancet Infect Dis; 2018 Dec; 18(12):1319-1328. PubMed ID: 30509675
[TBL] [Abstract][Full Text] [Related]
5. Imipenem/cilastatin in acute pulmonary exacerbations of cystic fibrosis.
Krilov LR; Blumer JL; Stern RC; Hartstein AI; Iglewski BN; Goldmann DA
Rev Infect Dis; 1985; 7 Suppl 3():S482-9. PubMed ID: 3901211
[TBL] [Abstract][Full Text] [Related]
6. Imipenem/cilastatin treatment of multiresistant Pseudomonas aeruginosa lung infection in cystic fibrosis.
Pedersen SS; Pressler T; Høiby N; Bentzon MW; Koch C
J Antimicrob Chemother; 1985 Nov; 16(5):629-35. PubMed ID: 3935639
[TBL] [Abstract][Full Text] [Related]
7. Improved Clinical Outcome After Treatment of Mycobacterium abscessus Complex Pulmonary Disease in Children With Cystic Fibrosis.
Chacko A; Wen SCH; Hartel G; Kapur N; Wainwright CE; Clark JE
Pediatr Infect Dis J; 2019 Jul; 38(7):660-666. PubMed ID: 30724835
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of respiratory isolates for Mycobacterium abscessus complex from pediatric patients.
Do PC; Nussbaum E; Moua J; Chin T; Randhawa I
Pediatr Pulmonol; 2013 May; 48(5):470-80. PubMed ID: 22833551
[TBL] [Abstract][Full Text] [Related]
9. Rapid detection and immune characterization of Mycobacterium abscessus infection in cystic fibrosis patients.
Steindor M; Nkwouano V; Mayatepek E; Mackenzie CR; Schramm D; Jacobsen M
PLoS One; 2015; 10(3):e0119737. PubMed ID: 25742660
[TBL] [Abstract][Full Text] [Related]
10. Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients.
Catherinot E; Roux AL; Vibet MA; Bellis G; Lemonnier L; Le Roux E; Bernède-Bauduin C; Le Bourgeois M; Herrmann JL; Guillemot D; Gaillard JL;
Eur Respir J; 2013 May; 41(5):1101-6. PubMed ID: 22936714
[TBL] [Abstract][Full Text] [Related]
11. Incidence of seizures in pediatric cancer patients treated with imipenem/cilastatin.
Karadeniz C; Oğuz A; Canter B; Serdaroğlu A
Pediatr Hematol Oncol; 2000; 17(7):585-90. PubMed ID: 11033734
[TBL] [Abstract][Full Text] [Related]
12. Successful lung transplantation for chronic Mycobacterium abscessus infection in advanced cystic fibrosis, a case series.
Raats D; Lorent N; Saegeman V; Vos R; van Ingen J; Verleden G; Van Raemdonck D; Dupont L
Transpl Infect Dis; 2019 Apr; 21(2):e13046. PubMed ID: 30597699
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic evaluation of imipenem combined with cilastatin in cystic fibrosis.
Bergan T; Michalsen H; Malmborg AS; Pedersen SS; Pressler T; Storrøsten OT; Strandvik B
Chemotherapy; 1993; 39(6):369-73. PubMed ID: 8222862
[TBL] [Abstract][Full Text] [Related]
14. Aerosolization of imipenem/cilastatin prevents pseudomonas-induced acute lung injury.
Hashimoto S; Wolfe E; Guglielmo B; Shanks R; Sundelof J; Pittet JF; Thomas E; Wiener-Kronish J
J Antimicrob Chemother; 1996 Nov; 38(5):809-18. PubMed ID: 8961050
[TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial activity of veterinary antibiotics (Apramycin and Framycetin) against
Moore JE; Koulianos G; Hardy M; Misawa N; Millar BC
Int J Mycobacteriol; 2018; 7(3):265-267. PubMed ID: 30198508
[TBL] [Abstract][Full Text] [Related]
16. Unusual Drug Fever Caused by Imipenem/Cilastatin and a Review of Literature.
Yang J; Wang Q; Wang S; Zhang Y; Wang Z
Heart Surg Forum; 2019 Mar; 22(2):E119-E123. PubMed ID: 31013221
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex.
Lavollay M; Dubée V; Heym B; Herrmann JL; Gaillard JL; Gutmann L; Arthur M; Mainardi JL
Clin Microbiol Infect; 2014 May; 20(5):O297-300. PubMed ID: 24112243
[TBL] [Abstract][Full Text] [Related]
18. Inhaled corticosteroids for cystic fibrosis.
Dezateux C; Walters S; Balfour-Lynn I
Cochrane Database Syst Rev; 2000; (2):CD001915. PubMed ID: 10796838
[TBL] [Abstract][Full Text] [Related]
19. Interaction of South Asian spices with conventional antibiotics: Implications for antimicrobial resistance for
Moore RE; Millar BC; Panickar JR; Moore JE
Int J Mycobacteriol; 2018; 7(3):257-260. PubMed ID: 30198506
[TBL] [Abstract][Full Text] [Related]
20. Nasopharyngeal
Kaji M; Namkoong H; Nagao G; Azekawa S; Nakagawara K; Tanaka H; Morita A; Asakura T; Kamata H; Uwamino Y; Yoshida M; Fukunaga K; Hasegawa N
Infect Drug Resist; 2023; 16():3955-3963. PubMed ID: 37361939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
